We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITOT icon
1326
iShares Core S&P Total US Stock Market ETF
ITOT
$93.7B
$40.7K ﹤0.01%
+324
New +$39.2K
PIO icon
1327
Invesco Global Water ETF
PIO
$274M
$38.3K ﹤0.01%
888
– –
LIT icon
1328
Global X Lithium & Battery Tech ETF
LIT
$1.46B
$36.8K ﹤0.01%
845
-1,593
-65% -$60.7K
VTWV icon
1329
Vanguard Russell 2000 Value ETF
VTWV
$1.3B
$35K ﹤0.01%
238
– –
AGNG icon
1330
Global X Aging Population ETF
AGNG
$88.7M
$34.5K ﹤0.01%
1,050
– –
ZOM
1331
DELISTED
Zomedica Corp.
ZOM
$33.3K ﹤0.01%
243,000
– –
IXUS icon
1332
iShares Core MSCI Total International Stock ETF
IXUS
$57.4B
$32.7K ﹤0.01%
450
– –
IWL icon
1333
iShares Russell Top 200 ETF
IWL
$2.16B
$31.7K ﹤0.01%
226
– –
FOX icon
1334
Fox Class B
FOX
$21.7B
$30.1K ﹤0.01%
777
+449
+137% +$16.2K
FWONA icon
1335
Liberty Media Series A
FWONA
$23.3B
$29.4K ﹤0.01%
411
-33
-7% -$2.32K
SPYD icon
1336
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.78B
$29.4K ﹤0.01%
644
– –
HEAL
1337
Global X Funds Global X HealthTech ETF
HEAL
$28.8M
$29.4K ﹤0.01%
977
– –
ISRA icon
1338
VanEck Israel ETF
ISRA
$151M
$29.4K ﹤0.01%
750
– –
GNOM icon
1339
Global X Genomics & Biotechnology ETF
GNOM
$78.9M
$28.1K ﹤0.01%
625
– –
VAW icon
1340
Vanguard Materials ETF
VAW
$3.05B
$27.5K ﹤0.01%
130
– –
FINX icon
1341
Global X FinTech ETF
FINX
$173M
$27.5K ﹤0.01%
980
-2,971
-75% -$78.4K
RSPF icon
1342
Invesco S&P 500 Equal Weight Financials ETF
RSPF
$311M
$25.4K ﹤0.01%
368
– –
PBR.A icon
1343
Petrobras Class A
PBR.A
$104B
$24.2K ﹤0.01%
1,835
+594
+48% +$8.05K
IYH icon
1344
iShares US Healthcare ETF
IYH
$3.46B
$22.4K ﹤0.01%
345
– –
RC
1345
Ready Capital
RC
$261M
$22.4K ﹤0.01%
2,934
-594
-17% -$5.04K
URA icon
1346
Global X Uranium ETF
URA
$5.41B
$22.1K ﹤0.01%
774
– –
IGF icon
1347
iShares Global Infrastructure ETF
IGF
$10.9B
$21.8K ﹤0.01%
+400
New +$20.5K
PSCH icon
1348
Invesco S&P SmallCap Health Care ETF
PSCH
$163M
$21.7K ﹤0.01%
471
– –
LLYVA icon
1349
Liberty Live Group Series A
LLYVA
$9.15B
$21.7K ﹤0.01%
439
-5
-1% -$195
IXC icon
1350
iShares Global Energy ETF
IXC
$2.68B
$20.6K ﹤0.01%
508
-221
-30% -$9.07K
52 53
54
55 56

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.